Fibrosis and Tissue Repair: From Molecules and Mechanics to Therapeutic Approaches (Q6)

Fibrosis and Tissue Repair: From Molecules and Mechanics to Therapeutic Approaches (Q6) is organized by Keystone Symposia on Molecular and Cellular Biology and will be held from Feb 19 - 23, 2020 at Fairmont Empress Hotel, Victoria, British Columbia, Canada.

Description
Fibrosis or scarring leads to destruction of organ architecture with loss of function and is an important cause of morbidity and mortality worldwide. Fibrosis affects nearly all tissues and organ systems and is a major pathogenic feature of many chronic inflammatory diseases including interstitial lung disease, NASH, glomerulonephritis, heart disease, Crohns disease, systemic sclerosis, among others. Fibrotic tissue remodeling also influences cancer metastasis and cancer therapy. Recent advances have provided a deeper understanding of the pathogenesis of fibrosis and have revealed novel drug targets that are at various stages of clinical development.

This conference, in conjunction with the joint meeting on stromal cells in immunity and disease, will bring together academic, clinical, and translational researchers to discuss core mechanisms driving inflammation and fibrosis, compare and contrast fibrotic diseases of different organs, discuss the best preclinical models, and debate emerging therapies. This will be the 7th Keystone Symposium on Fibrosis, which was established in 2007 and is intended to be the premier international meeting for anyone with an interest in fibrosis. The meeting brings together researchers from a broad range of interests including epithelial biology, vascular biology, cancer, stem and tissue progenitor cell biology, tissue repair and regeneration, as well as those with disease specific-interests.

 Additional details will be posted as soon as they are available.